#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune demyelinating disease Inborn error of metabolism Raynaud's phenomenon Antiphospholipid antibodies Deafness Splenic marginal zone lymphoma Henoch-Schonlein purpura nephritis Hereditary optic atrophy Candida infection Diffuse large B-cell lymphoma Haemophagocytic lymphohistiocytosis Selective polysaccharide antibody deficiency Proteus syndrome Dermatitis Arginase deficiency More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Basic Information Ewing’s sarcoma recurrent – Basic Information Myelodysplastic syndrome with excess blasts – Trials in Disease Paraneoplastic neurological syndrome Immunodeficiency congenital – Diagnostics Osteosarcoma – Diagnostics Systemic mastocytosis – Diagnostics Synovial sarcoma recurrent – Trials in Disease Metachromatic leukodystrophy – Life with Disease Friedreich’s ataxia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Omp12 Camizestrant Siponimod Tozinameran Amlodipine Relatlimab AMLENETUG CYCLIZINE HYDROCHLORIDE Dobutamine MORPHINE Somatostatin Clopidogrel Nitric Oxide Flortaucipir (18F) VG801-2 Befiradol (18F) Pyridoxine Hydrochloride Donepezil Hydrochloride Poa Pratensis Pollen Extract SOFTISAN 378 More therapies…

    Learn about Your Condition

    Type V hyperlipidaemia Eyelid ptosis CADASIL Frontotemporal dementia Hyperadrenocorticism Cortical dysplasia Arginase deficiency Hypoalbuminaemia Toxicity to various agents Alpha-1 antitrypsin deficiency Magnetic resonance imaging Osteonecrosis of jaw Brain cancer metastatic Erythema Hypochondroplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study of Cemiplimab Combined with Imiquimod and Laser Therapy Before Surgery for High-Risk Skin Basal Cell Carcinoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Imiquimod
    • Cemiplimab
    Spain

  • Effectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis

    Recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Abrocitinib
    Germany Hungary Poland Spain

  • Study on the Effectiveness of Clostridium Botulinum Neurotoxin Type A for Reducing Wrinkles in Adults

    Recruiting

    4 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    The Netherlands

  • Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Upadacitinib
    Belgium Poland

  • Treatment with Mesenchymal Stromal Cells for Adults with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS-TEN) Affecting More Than 10% of Body Surface

    Recruiting

    1 1 1
    Investigated Diseases:
    • Toxic epidermal necrolysis
    Investigated Drugs:
    • Allogeneic Adipose-Derived Mesenchymal Stromal Cells, Ex-Vivo Expanded
    France

  • Study on the Safety and Effectiveness of Metal Panel Allergens for Patients with Allergic Contact Dermatitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • AMMONIUM TITANIUM OXALATE MONOHYDRATE
    • GOLD SODIUM THIOSULFATE
    • MANGANESE CHLORIDE TETRAHYDRATE
    Germany Italy The Netherlands
Previous Page
1 … 5 6 7 8 9 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!